What the 2024 MHPAEA Final Rule Actually Changed for Your Denials Workflow

The October 2024 MHPAEA final rule is not theoretical for the practices we work with. Across roughly 50 behavioral health practices we support in RCM, the pattern is consistent: payers are still applying nonquantitative treatment limitations (NQTLs) to mental health and substance use disorder claims at rates that would never survive scrutiny on a comparable medical or surgical benefit. The final rule, effective for plan years beginning on or after January 1, 2025, gives your appeals team new statutory teeth. The question is whether you know how to use them.

Most BH CFOs we talk to know the rule exists but are still treating parity appeals as a long-shot afterthought. That is a revenue leak. We are seeing practices recover between $18,000 and $62,000 per year in previously written-off parity-related denials once they implement a structured NQTL analysis and appeal workflow. This post walks through exactly what that looks like in 2026 operational terms.

Understanding NQTL Analysis Under the Final Rule

An NQTL is any limitation on benefits that is not expressed as a dollar amount or visit cap. Under the 2024 final rule, plans must now demonstrate that any NQTL applied to mental health or SUD benefits is no more restrictive than the predominant limitation applied to substantially all medical and surgical benefits in the same classification. That standard existed before, but the final rule adds three critical enforcement upgrades:

• Comparative analysis must be documented in writing and produced to enrollees or providers upon request within 30 days.
• Plans must use the same evidentiary standards and sources when designing NQTLs for MH/SUD and med/surg benefits. Asymmetric clinical criteria is now explicitly prohibited.
• Self-funded plans subject to ERISA face direct Department of Labor enforcement, with the DOL authorized to publish non-compliance findings publicly.

For your billing team, this means every prior authorization denial for CPT codes 90832, 90834, 90837, 90847, 90853, 90839, and 99213-99215 billed under POS 11 or POS 53 is now potentially a parity violation if the payer cannot show equivalent PA requirements apply to comparable med/surg services. We review denial reason codes at the EOB level and routinely find CO-197 and CO-50 denials that are NQTL violations hiding as routine administrative denials.

The NQTL Categories Most Likely Hitting Your Receivables Right Now

Not all NQTLs carry the same revenue impact. Based on what we see across practices billing ABA (CPT 97151-97158), intensive outpatient (H0015, POS 72), and individual therapy, the highest-impact NQTL categories in 2026 are:

• Prior authorization frequency limits: Payers requiring PA reauthorization every 4-8 sessions for CPT 90837 while med/surg services like physical therapy (CPT 97110) receive 60-day or episode-of-care authorizations with no resubmission requirement.
• Step therapy and fail-first protocols: Requiring documented failure of lower levels of care before authorizing PHP (H0035, POS 52) or IOP, while no equivalent step protocol applies to inpatient medical admissions.
• Geographic and network adequacy restrictions: Narrower in-network panels for MH/SUD providers, forcing out-of-network billing at lower reimbursement rates without equivalent restrictions on specialty surgical care.
• Concurrent review burdens: Requiring discharge planning documentation every 3-5 days for residential SUD treatment (H2036, POS 56) versus 7-10 day intervals for comparable medical inpatient stays.

Each of these is an NQTL. Each is now potentially actionable under the final rule if you can document the disparity. We cover the foundational appeal strategy for these scenarios in more detail in our MHPAEA parity appeals resource for behavioral health practices, which is worth reviewing alongside the regulatory text.

Building Your NQTL Documentation Package for Appeals

The appeal that wins is the one with a paper trail the payer cannot ignore. Here is the documentation stack we build for every NQTL-based parity appeal:

• The formal NQTL comparative analysis request: Submitted in writing to the payer’s appeals or compliance department citing 29 CFR 2590.712 and the 2024 final rule. Request the specific written analysis the plan is required to produce. If they miss the 30-day window, that non-compliance becomes part of your external review record.
• Side-by-side benefit comparison: Pull the Summary Plan Description and identify two to three comparable med/surg services. Document the authorization requirements for each. For a payer requiring PA on every CPT 90837 session block, compare their PT or occupational therapy authorization protocol.
• Claim-level data export: Pull all denials by reason code for the trailing 12 months. Sort by CO-197, CO-50, CO-4, and PR-96. Cluster by procedure code and payer. A pattern across 15 or more claims is substantively different from a one-off denial and supports a systemic parity complaint to the DOL or your state insurance commissioner.
• Clinical necessity letter with parity framing: The treating clinician’s letter should explicitly note that the service would not require this level of administrative review if it were a medical or surgical benefit, and should request that the payer apply equivalent standards.

For practices with SUD service lines also billing drug screening, the NQTL analysis sometimes intersects with coding gaps we see on the lab side. If your SUD clinic is running presumptive or definitive screens and not capturing full reimbursement on G0480-G0483, that is a separate but compounding revenue problem covered in our drug screen coding guide for SUD practices.

Revenue Recovery Benchmarks by Practice Size

We want to give you a realistic expectation for what a structured parity appeals program returns. These figures reflect actual recovery ranges we track across our client base, not modeled projections:

• Solo or small group practice (1-5 clinicians): $8,000 to $22,000 per year in recovered parity denials, primarily from PA-related CO-197 appeals on CPT 90837 and 90847.
• Mid-size BH practice (6-20 clinicians): $25,000 to $62,000 per year, with the largest recoveries typically on IOP authorization appeals under H0015 and H0035 billed to commercial plans.
• Larger multi-site or CCBHC-affiliated practices (20+ clinicians): $75,000 to $180,000 per year when NQTL appeals are combined with external review escalations and DOL complaints where warranted.

The variance comes down to payer mix and how systematically you work the denial queue. Practices that treat parity appeals as a compliance task rather than a revenue cycle function consistently underperform on recovery. The parity appeal belongs in your AR workflow, not in a compliance binder.

External Review and Escalation: When to Push Further

If your internal appeal is denied and the NQTL documentation is solid, the 2024 final rule supports escalation through two additional channels. First, request external independent review. Under the ACA and ERISA, most fully insured plans and many self-funded plans must offer external review for adverse benefit determinations. An external reviewer with NQTL analysis experience who finds a parity violation creates an overturn you can enforce. Second, file a formal parity complaint with the DOL’s Employee Benefits Security Administration (EBSA) for ERISA plans, or your state insurance department for fully insured plans. State regulators in California, New York, Illinois, and Colorado have active parity enforcement programs with public violation tracking. A confirmed complaint finding strengthens every subsequent appeal across that payer’s book of business.

The practices that recover the most are the ones that document systematically, escalate strategically, and treat every NQTL denial as both a revenue opportunity and a compliance enforcement moment. The 2024 final rule made the payer’s burden of proof heavier. Your job is to make sure they carry it.

Start With a Denial Audit Before You Build the Program

If you are not sure where your parity exposure actually lives right now, the most useful first step is a denial-level audit that segments your CO-197, CO-50, and related denial reason codes by payer and procedure code across the trailing 12 months. We offer a free 30-day denial audit for behavioral health practices that want a clear picture of their parity appeal opportunity before committing to a full program. To schedule time with our billing team and get your audit started, book directly on our calendar here. No obligation, and you will leave the call knowing exactly which denials are worth fighting.